• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • APEIRON Biologics’ APN01 Selected for US COVID-19 Trail americanpharmaceuticalreview
    May 20, 2021
    APEIRON Biologics, a private European biotech company, announced next steps for APN01 (alunacedase alfa) for COVID-19 treatment.
  • APEIRON Appoints CMSO contractpharma
    August 29, 2018
    APEIRON Biologics AG has appointed Anderson Gaweco, M.D., Ph.D. as its chief medical and scientific officer (CMSO).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service